Drug and Medication Analysis & Statistics, March 2015

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

1-30 of about 7 500 reports

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

  • Industries : Hospitality, Hospitality, Tourism, Tourism, Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : World, Europe
PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with ...

  • Industries : Pharmaceutical, Therapy
  • Countries : Europe, World
Exenatide  - Comprehensive patent search

Exenatide - Comprehensive patent search

  • $ 10 118
  • Industry report
  • March 2015
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...

  • Industries : Drug and Medication
OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018

  • $ 7 995
  • Industry report
  • December 2014
  • by Global Data

OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018 Summary GlobalData estimates the 2013 sales for acromegaly and gigantism at approximately $588m across the 6MM ...

  • Industries : Drug and Medication
Nevirapine  - Comprehensive patent search

Nevirapine - Comprehensive patent search

  • $ 8 160
  • Industry report
  • March 2015
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...

  • Industries : Drug and Medication
Global Feed additives market - Growth, Trends And Forecasts (2014-2020)

Global Feed additives market - Growth, Trends And Forecasts (2014-2020)

  • $ 7 500
  • Industry report
  • January 2015
  • by Mordor Intelligence LLP

Feed additives are important in animal nutrition as they improve the quality of feed thus improving animal’s performance and health subsequently improving the yield and quality of food from animal origin. ...

  • Industries : Drug and Medication, Food Manufacturing, Food Manufacturing
Frontier Pharma: Pain - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Pain - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • January 2015
  • by GBI Research

Frontier Pharma: Pain - Identifying and Commercializing First-in-Class Innovation Summary Large and Innovative Pipeline The active pain pipeline is populated by 796 products across all stages of development, ...

  • Industries : Drug and Medication
  • Countries : United States
PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered ...

  • Industries : Pharmaceutical, Therapy
  • Countries : Europe
Frontier Pharma: Antibiotics - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Antibiotics - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • December 2014
  • by GBI Research

Frontier Pharma: Antibiotics - Identifying and Commercializing First-in-Class Innovation Summary An Extensive Developmental Pipeline, but Limited First in Class Innovation The antibiotics pipeline is very ...

  • Industries : Drug and Medication
  • Countries : United States
Global Markets for Allergy Diagnostics and Treatments

Global Markets for Allergy Diagnostics and Treatments

  • $ 6 650
  • Industry report
  • February 2015
  • by BCC Research

REPORT HIGHLIGHTS Global allergy diagnostic and treatment market is projected to increase to nearly $35.3 billion by 2015 from $31.5 billion in 2014. This market is expected to reach $46.8 billion by 2020, ...

  • Industries : Drug and Medication
  • Countries : World
Global Markets for Drug-Device Combinations

Global Markets for Drug-Device Combinations

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The sales of drug-device combination products reached $21.4 billion in 2013 and $22 billion in 2014. This market is expected to grow to $31 billion in 2019, with a compound annual growth ...

  • Industries : Drug and Medication
Global Markets for Animal Therapeutics and Diagnostics

Global Markets for Animal Therapeutics and Diagnostics

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for animal therapeutics and diagnostics totaled $37.8 billion in 2014 and is expected to reach about $46.5 billion in 2019, registering a compound annual growth rate ...

  • Industries : Drug and Medication
  • Countries : World
Antibody Drugs: Technologies and Global Markets

Antibody Drugs: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for antibody drugs was worth nearly $63.4 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 12.2% between 2014 and 2019 resulting ...

  • Industries : Biopharmaceutical
  • Countries : World
Opportunity in the Indian Anti-Infective Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Anti-Infective Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 5 000
  • Industry report
  • March 2015
  • by Feedback Business Consulting

This report provides an insight into the Indian Anti-Infective Pharmaceuticals current market scenario, structure and practices. In depth market scenario includes; - Current market size estimate - Market ...

  • Industries : Drug and Medication
  • Countries : India
Opportunity in the Indian Cardiovascular Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Cardiovascular Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 5 000
  • Industry report
  • March 2015
  • by Feedback Business Consulting

This report provides an insight into the Indian Cardiovascular Pharmaceuticals current market scenario, structure and practices. In depth market scenario includes; - Current market size estimate - Market ...

  • Industries : Drug and Medication
  • Countries : India
A Product and Pipeline Analysis of the Antibacterial Drugs Market : Regulatory Approaches to Combat Microbial Resistance and Stimulate Antibiotics R&D

A Product and Pipeline Analysis of the Antibacterial Drugs Market : Regulatory Approaches to Combat Microbial Resistance and Stimulate Antibiotics R&D

  • $ 5 000
  • Industry report
  • January 2015
  • by Frost & Sullivan

Key Findings •2014 has turned out to be a flagship year in the history of antibacterial drugs development. oThree new systemic antibacterial drugs gained Food and Drugs Administration (FDA) approval ...

  • Industries : Drug and Medication
  • Countries : United States
Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics

  • $ 4 995
  • Industry report
  • January 2015
  • by GBI Research

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Pharmaceutical, Pathology, Therapy, General Medicine and Specialty Medicine, Healthcare
  • Countries : World, Europe
PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : Australia, Oceania
PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : China, Asia
PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : India, Asia
PharmaPoint: Irritable Bowel Syndrome - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - US Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered ...

  • Industries : Pharmaceutical
  • Countries : Japan, World
PharmaPoint: Irritable Bowel Syndrome - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - Japan Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - Japan Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with ...

  • Industries : Pharmaceutical
  • Countries : Japan
Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

  • $ 4 995
  • Industry report
  • December 2014
  • by GBI Research

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth Summary Increasingly Crowded Market for Second-Line Therapies Improving Treatment Options for Moderate-to-Severe Rheumatoid ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
World Intravenous (IV) Iron Drugs Industry

World Intravenous (IV) Iron Drugs Industry

  • $ 4 950
  • Industry report
  • January 2015
  • by Global Industry Analysts

This report analyzes the worldwide markets for Intravenous (IV) Iron Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, ...

  • Industries : Drug and Medication
  • Countries : Europe, World
Dermatology Devices Market by Diagnostic Devices (Dermatoscope, Microscope, Imaging Techniques), Treatment Devices (Liposuction, Microdermabrasion, Lasers) & by Application (Cancer Diagnosis, Acne, Psoriasis, Hair Removal) - Global Forecast to 2019

Dermatology Devices Market by Diagnostic Devices (Dermatoscope, Microscope, Imaging Techniques), Treatment Devices (Liposuction, Microdermabrasion, Lasers) & by Application (Cancer Diagnosis, Acne, Psoriasis, Hair Removal) - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • January 2015
  • by MarketsandMarkets

In this report, the dermatology devices market is segmented on the basis of applications, products, and geographies. The application segments included in this report are diagnostic applications and treatment ...

  • Industries : Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : World, Asia, North America
Mivacurium chloride Chemical Report

Mivacurium chloride Chemical Report

  • $ 4 609
  • Industry report
  • March 2015
  • by PureData

Mivacurium chloride Chemical Report This Mivacurium chloride Chemical World Consumption Reportt provides data on the net consumption of Mivacurium chloride in each of the countries listed. The substance ...

  • Industries : Advertising and Marketing, Drug and Medication, Marketing, Marketing
  • Countries : World
4-(Methylamino)benzoic acid Chemical Report

4-(Methylamino)benzoic acid Chemical Report

  • $ 4 609
  • Industry report
  • March 2015
  • by PureData

4-(Methylamino)benzoic acid Chemical Report This 4-(Methylamino)benzoic acid Chemical World Consumption Reportt provides data on the net consumption of 4-(Methylamino)benzoic acid in each of the countries ...

  • Industries : Advertising and Marketing, Marketing, Marketing
  • Countries : World
Rufinamide Chemical Report

Rufinamide Chemical Report

  • $ 4 609
  • Industry report
  • March 2015
  • by PureData

Rufinamide Chemical Report This Rufinamide Chemical World Consumption Reportt provides data on the net consumption of Rufinamide in each of the countries listed. The substance covered (Rufinamide) are ...

  • Industries : Advertising and Marketing, Marketing, Marketing
  • Countries : World
Clinafloxacin hydrochloride Chemical Report

Clinafloxacin hydrochloride Chemical Report

  • $ 4 609
  • Industry report
  • March 2015
  • by PureData

Clinafloxacin hydrochloride Chemical Report This Clinafloxacin hydrochloride Chemical World Consumption Reportt provides data on the net consumption of Clinafloxacin hydrochloride in each of the countries ...

  • Industries : Advertising and Marketing, Marketing, Marketing
  • Countries : World
Cefditoren sodium Chemical Report

Cefditoren sodium Chemical Report

  • $ 4 609
  • Industry report
  • March 2015
  • by PureData

Cefditoren sodium Chemical Report This Cefditoren sodium Chemical World Consumption Reportt provides data on the net consumption of Cefditoren sodium in each of the countries listed. The substance covered ...

  • Industries : Advertising and Marketing, Drug and Medication
  • Countries : World

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.